1. Iridium(III) carbene complexes as potent girdin inhibitors against metastatic cancers
   Mei-Ling Ruan et al, 2024, Proceedings of the National Academy of Sciences CrossRef
2. Combination of cytoplasmic and nuclear girdin expression is an independent prognosis factor of breast cancer
   Huikun Zhang et al, 2018, The FASEB Journal CrossRef
3. GIV/Girdin (Gα-interacting, Vesicle-associated Protein/Girdin) Creates a Positive Feedback Loop That Potentiates Outside-in Integrin Signaling in Cancer Cells
   Anthony Leyme et al, 2016, Journal of Biological Chemistry CrossRef
4. Girdin protein: A potential metastasis predictor associated with prognosis in lung cancer
   Zhaoyang Yang et al, 2018, Experimental and Therapeutic Medicine CrossRef
5. Prognostic impact of total and tyrosine phosphorylated GIV/Girdin in breast cancers
   Ying Dunkel et al, 2016, The FASEB Journal CrossRef
6. Integrins activate trimeric G proteins via the nonreceptor protein GIV/Girdin
   Anthony Leyme et al, 2015, Journal of Cell Biology CrossRef
7. Girdin (GIV) Expression as a Prognostic Marker of Recurrence in Mismatch Repair–Proficient Stage II Colon Cancer
   Pradipta Ghosh et al, 2016, Clinical Cancer Research CrossRef
8. Heterotrimeric G proteins as emerging targets for network based therapy in cancer: End of a long futile campaign striking heads of a Hydra
   Pradipta Ghosh, 2015, Aging CrossRef
9. Long noncoding RNA MEG3 prevents vascular endothelial cell senescence by impairing miR-128-dependent Girdin downregulation
   Yong Lan et al, 2019, American Journal of Physiology-Cell Physiology CrossRef